Navigation Links
Arpida Interim Results for six Months to 30 June 2007
Date:8/28/2007

ggest that monitoring may not be required. This could be an important competitive advantage in the clinical setting.

In March, patient enrolment in ASSIST-2, the second pivotal Phase III trial with iclaprim in complicated skin and skin structure (cSSSI) was completed. Top-line results were published on 15 July 2007. These showed that the pre-specified primary endpoint of the second trial was achieved, as it was in the first.

The next step will be to discuss the data with the regulatory authorities and define the path forward for the filing of a New Drug Application (NDA) which is expected to take place in the course of this year.

Intravenous iclaprim - Additional indications

In June 2007, the US FDA granted authorisation to initiate a Phase II trial with intravenous iclaprim in the treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) or healthcare-associated pneumonia (HCAP) suspected or confirmed to be due to Gram-positive pathogens. Results of this trial are expected in the course of 2008.

Oral iclaprim

Additional Phase I trials are currently ongoing. After completion of these trials, efficacy trials could be undertaken.

TLT

In July 2007, Arpida announced the acquisition of TLT Medical Ltd., a Swiss privately-owned biopharmaceutical company with an innovative onychomycosis (OM) therapy. European regulatory authorities have granted authorisation to initiate a pivotal Phase III clinical trial that aims to demonstrate superiority of the TLT therapy compared to the standard of care topical treatment for mild to moderate OM. Enrolment is expected to start in the short term and filing for approval could be expected in late 2008 or early 2009.

AR-709 First-in-man successfully completed

AR-709 originates from Arpidas own drug discovery efforts. It is a bactericidal antibiotic that is being developed for the treatment of upper and lower respiratory tract infections co
'/>"/>

SOURCE Arpida
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Effects of Thermal Cycler Well-To-Well Temperature Uniformity on PCR Results
2. HotMasterAn innovative Hot Start/Cold Stop technology for better PCR* results
3. Achieving Reliable Protein Quantitation Results Using ICAT Reagents, MALDITOF Mass Spectrometry, and Advanced Data Interpretation Tool
4. How Best Buy said bye to burnout, hello to results
5. Economic survey reveals better 2006 results
6. Third Wave Reports Third-Quarter Financial Results
7. Tech Digest: Merge eMed product updates; Renaissance Learning 3rd qtr results
8. Midwest small-cap life sciences turn in mixed third-quarter results
9. To boost advertising results, consider improving your web site
10. RedPrairie Reports Strong Results
11. 2003 Biotech Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014  The In Silico Drug Discovery Conference today ... at the conference, which takes place at North Carolina ... 4, 2014. Researchers, students, drug developers, business development professionals, ... KEYNOTE SPEAKERS Ruben ... of Pharmacy Drug Discovery with Three Dimensional ...
(Date:9/17/2014)... , Sept. 17, 2014  MiMedx Group, Inc. ... processor and marketer of patent protected regenerative biomaterials ... today the publication of another peer-reviewed clinical study.    ... A Multi-center Randomized Controlled Clinical Trial Evaluating the ... Membrane Allografts and Multi-layer Compression Therapy vs. Multi-layer ...
(Date:9/17/2014)... NEWTOWN, Pa. , Sept. 17, 2014 ... services and eClinical Solutions, today announced three of its ... Conference for Clinical Data Management to be held ... Vegas, Nevada . The Company also announced the ... to raise overall quality in clinical trials acquired earlier ...
(Date:9/17/2014)... Intarcia Therapeutics, Inc. today announced ... of the cost and predictability of non-adherence in type ... Meeting of the European Association for the Study of ... Frois , Ph.D., of Analysis Group, Inc. presented data ... retrospective studies to characterize the prevalence of non-adherence and ...
Breaking Biology Technology:In Silico Drug Discovery Conference Announces Speakers and Topics 2In Silico Drug Discovery Conference Announces Speakers and Topics 3In Silico Drug Discovery Conference Announces Speakers and Topics 4In Silico Drug Discovery Conference Announces Speakers and Topics 5In Silico Drug Discovery Conference Announces Speakers and Topics 6In Silico Drug Discovery Conference Announces Speakers and Topics 7MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 2MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 3MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 4BioClinica to Present at 20th Annual SCDM Conference 2BioClinica to Present at 20th Annual SCDM Conference 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5
... NORTH BILLERICA, Mass., March 2, 2011 Seahorse Bioscience, ... instruments for assessing cellular bioenergetics, has announced In Vitro ... XF Analyzers and consumables in Australia and New Zealand. ... first and only kinetic method to measure the two ...
... program by one of the world,s largest cities to switch ... harmful vehicle emissions in more than 5,000 vehicles and ... British Columbia study finds. The study which explores ... buses, taxis and auto-rickshaws to compressed natural gas (CNG), a ...
... 2011 Life Technologies Corporation (Nasdaq: ... management presentations to investors as part of the UBS ... is being held at the company,s headquarters in Carlsbad ... Stevenson, Life Technologies, President and Chief Operating Officer, will ...
Cached Biology Technology:Seahorse Bioscience, Inc. Appoints In Vitro Technologies Pty Ltd as New Distributor in Australia and New Zealand 2Clean fuel worsens climate impacts for some vehicle engines: UBC study 2Life Technologies to Webcast Investor Presentation as Part of the UBS West Coast Life Sciences & Diagnostics Bus Trip 2
(Date:9/17/2014)... about complex social behavior by studying nonhuman mammals and ... , With their unusually large brains relative to their ... complex social environment---not merely in a large population of ... a dynamic setting of alliances and competitors. The same ... primates, and social carnivores, like hyenas and lions. , ...
(Date:9/16/2014)... NEW YORK (17 September, 2014)More than $100 trillion ... megatons of annual carbon dioxide (CO2)a 40 percent ... by 2050 if the world expands public transportation, ... new report released by the University of California, ... Policy (ITDP). , Further, an estimated 1.4 ...
(Date:9/16/2014)... Each tree species has its own bacterial identity. That,s ... from other institutions who studied the genetic fingerprints of ... Panamanian island. , "This study demonstrates for the first ... with different ecological strategies possess very different microbial communities ... a former postdoctoral researcher in the UO,s Institute of ...
Breaking Biology News(10 mins):Being social: Learning from the behavior of birds 2Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 2Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 3Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 4Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 5Microbiome research shows each tree species has a unique bacterial identity 2
... GAINESVILLE, Fla. The percentage of electronic waste occupying our ... decade, giving rise to concerns about the toxicity of components ... of Florida are looking for ways to minimize environmental hazards ... role in the manufacture of these goods in the future. ...
... 2012  The universal adoption of biometric passports will influence ... for the global civil and military biometrics market in ... the police and the military will become a common ... is set for almost universal use in the identification ...
... and the US led by Jakob Christensen-Dalsgaard, University of Southern ... the turtle ear is specialized for underwater hearing. The new ... B March 21st , Special features of the turtle ... tympanic disk increase its sensitivity for underwater sound. Laser measurements ...
Cached Biology News:UF researchers look for ways to make an emerging technology safe for environment 2Heightened Security Threats and Economic Issues Provide Fillip to Global Civil and Military Biometrics Market, Says Frost & Sullivan 2Heightened Security Threats and Economic Issues Provide Fillip to Global Civil and Military Biometrics Market, Says Frost & Sullivan 3
... timer, SB3, Fully adjustable mixing angle, Variable ... to hold a number of different sized ... for aerating cultures, keeping biological samples in ... rotator can be used in incubators up ...
... C6 Flow Cytometer System is a full featured, ... including: the C6 Flow Cytometer, CFlow Software, and ... Flow Cytometer System provides all the capabilities of ... of the price. The C6 Flow Cytometer System ...
... II multiscreen apparatus is used to screen blots ... The apparatus can screen up to 40 different ... blot into strips. The apparatus includes a base ... one or two 8 x 7 cm membranes, ...
Fingerprinting II Informatix cluster analysis is an optional module that adds dendrogram and phylogenetic tree construction, cluster and group significance, and congruence of techniques functions to ...
Biology Products: